Skip to Main Content

Author Details

Nicholas K Hayward
QIMR Berghofer Medical Research Institute
1982
399
89
PMIDPaper TitleJournal TitlePublished Year
36863448Germline Variants in Childhood Cutaneous Melanoma.J Invest Dermatol2023
37646013<i>TINF2</i> is a major susceptibility gene in Danish patients with multiple primary melanoma.HGG Adv2023
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
36863448Germline Variants in Childhood Cutaneous Melanoma.J Invest Dermatol2023
36617535Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment.Pigment Cell Melanoma Res2023
36790412Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.Clin Cancer Res2023
36847278Habitual consumption of high-fibre bread fortified with bean hulls increased plasma indole-3-propionic concentration and decreased putrescine and deoxycholic acid faecal concentrations in healthy volunteers.Br J Nutr2023
37646013<i>TINF2</i> is a major susceptibility gene in Danish patients with multiple primary melanoma.HGG Adv2023
36790412Intratumoral CD16+ Macrophages Are Associated with Clinical Outcomes of Patients with Metastatic Melanoma Treated with Combination Anti-PD-1 and Anti-CTLA-4 Therapy.Clin Cancer Res2023
36617535Immune signatures in cutaneous melanoma correlate with survival independently of immunotherapy treatment.Pigment Cell Melanoma Res2023
36876055Association of germline variants in telomere maintenance genes (<i>POT1, TERF2IP, ACD,</i> and <i>TERT</i>) with spitzoid morphology in familial melanoma: A multi-center case series.JAAD Int2023
36847278Habitual consumption of high-fibre bread fortified with bean hulls increased plasma indole-3-propionic concentration and decreased putrescine and deoxycholic acid faecal concentrations in healthy volunteers.Br J Nutr2023
35229492Systematic review and meta-analysis of genomic alterations in acral melanoma.Pigment Cell Melanoma Res2022
35462085Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.J Thorac Oncol2022
36098958Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Cancer Discov2022
35365243Choroidal melanoma with synchronous Fuchs' adenoma and novel ATRX mutation.Int J Retina Vitreous2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
35229492Systematic review and meta-analysis of genomic alterations in acral melanoma.Pigment Cell Melanoma Res2022
35149587Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.Cancer Res2022
34951955Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.Cancer Cell2022
35462085Medical and Surgical Care of Patients With Mesothelioma and Their Relatives Carrying Germline BAP1 Mutations.J Thorac Oncol2022
35365243Choroidal melanoma with synchronous Fuchs' adenoma and novel ATRX mutation.Int J Retina Vitreous2022
35355015Anatomic position determines oncogenic specificity in melanoma.Nature2022
36098958Comparative Genomics Provides Etiologic and Biological Insight into Melanoma Subtypes.Cancer Discov2022
34951955Multiomic profiling of checkpoint inhibitor-treated melanoma: Identifying predictors of response and resistance, and markers of biological discordance.Cancer Cell2022
35149587Combined Inhibition of G9a and EZH2 Suppresses Tumor Growth via Synergistic Induction of IL24-Mediated Apoptosis.Cancer Res2022
32989607FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.Fam Cancer2021
33707307Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.Mol Cancer Res2021
34076666Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.JAMA Dermatol2021
33589432G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.Clin Cancer Res2021
34262154Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.Genet Med2021
33664264Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.Nat Commun2021
33513031Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in <i>BAP1</i> Pathogenic Variant Carriers.JCO Clin Cancer Inform2021
32989607FRAMe: Familial Risk Assessment of Melanoma-a risk prediction tool to guide CDKN2A germline mutation testing in Australian familial melanoma.Fam Cancer2021
32907878Loss-of-function variants in <i>POT1</i> predispose to uveal melanoma.J Med Genet2021
33216348A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies.Br J Haematol2021
33410475Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.Hum Mol Genet2021
33513031Microsimulation Model for Evaluating the Cost-Effectiveness of Surveillance in <i>BAP1</i> Pathogenic Variant Carriers.JCO Clin Cancer Inform2021
33707307Meta-Analysis and Systematic Review of the Genomics of Mucosal Melanoma.Mol Cancer Res2021
33589432G9a Inhibition Enhances Checkpoint Inhibitor Blockade Response in Melanoma.Clin Cancer Res2021
33664264Evolution of late-stage metastatic melanoma is dominated by aneuploidy and whole genome doubling.Nat Commun2021
34076666Evaluation of Crizotinib Treatment in a Patient With Unresectable GOPC-ROS1 Fusion Agminated Spitz Nevi.JAMA Dermatol2021
34262154Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia.Genet Med2021
33216348A rare missense variant in protection of telomeres 1 (POT1) predisposes to a range of haematological malignancies.Br J Haematol2021
33410475Germline variants are associated with increased primary melanoma tumor thickness at diagnosis.Hum Mol Genet2021
32907878Loss-of-function variants in <i>POT1</i> predispose to uveal melanoma.J Med Genet2021
32557800Cluster of pregnancy-associated melanoma: A case report and brief update.J Dermatol2020
32081490Whole Exome Sequencing Identifies Candidate Genes Associated with Hereditary Predisposition to Uveal Melanoma.Ophthalmology2020
32249419Co-targeting bromodomain and extra-terminal proteins and MCL1 induces synergistic cell death in melanoma.Int J Cancer2020
32415113Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours.Nat Commun2020
  • 1 - 50 of 798

Recommended Authors

Lawrence N Kwong
The University of Texas MD Anderson Cancer Center
Career Start Year 2007
Number of shared co-authors 13
Heidi V N K??sters-Vandevelde
Canisius Wilhelmina Hospital
Career Start Year 2006
Number of shared co-authors 1
Robert C Onofrio
The Broad Institute of Harvard and MIT
Career Start Year 2005
Number of shared co-authors 20
J??r??mie Nsengimana
Population Health Sciences Institute, Newcastle University
Career Start Year 2004
Number of shared co-authors 15
Vladimir Makarov
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 14
Marcory C R F van Dijk
1Rijnstate Hospital
Career Start Year 2001
Number of shared co-authors 0
Daniela Mihic-Probst
University Hospital Zurich
Career Start Year 2001
Number of shared co-authors 6
Mairin Rafferty
Oncomark Ltd.
Career Start Year 2001
Number of shared co-authors 5
Tobias Sj??blom
Uppsala University
Career Start Year 1999
Number of shared co-authors 5
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 12
Dirce Maria Carraro
AC Camargo Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Anne-Marie Martin
Novartis Pharmaceuticals
Career Start Year 1995
Number of shared co-authors 4
Curtis Gumbs
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 6
Aaron G Smith
Dermatology Research Centre, UQ Diamantina Institute, The University of Queensland
Career Start Year 1995
Number of shared co-authors 15
Marbin Pineda
Center for Cancer Research, National Cancer Institute
Career Start Year 1995
Number of shared co-authors 20
Zhengping Zhuang
National Cancer Institute, National Institutes of Health
Career Start Year 1994
Number of shared co-authors 5
Ashani T Weeraratna
Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine
Career Start Year 1992
Number of shared co-authors 26
Phillip A Futreal
The University of Texas MD Anderson Cancer Center
Career Start Year 1991
Number of shared co-authors 29
Levi A Garraway
Broad Institute of Harvard and MIT
Career Start Year 1991
Number of shared co-authors 23
Suzanne Carreira
The Institute of Cancer Research
Career Start Year 1990
Number of shared co-authors 7
Bharati Bapat
Mt Sinai Hospital
Career Start Year 1988
Number of shared co-authors 5
Eivind Hovig
Center for Bioinformatics, University of Oslo
Career Start Year 1987
Number of shared co-authors 12
Michael R Stratton
Wellcome Sanger Institute
Career Start Year 1987
Number of shared co-authors 54
Katherine L Nathanson
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 51
Arupa Ganguly
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1983
Number of shared co-authors 2
Dave S B Hoon
Saint John's Cancer Institute at Saint John's Health Center
Career Start Year 1982
Number of shared co-authors 27
Stephen N Thibodeau
Mayo Clinic
Career Start Year 1978
Number of shared co-authors 40
Webster K Cavenee
Ludwig Institute for Cancer Research, University of California San Diego
Career Start Year 1977
Number of shared co-authors 7
Irene L Andrulis
University of Toronto
Career Start Year 1977
Number of shared co-authors 57
Paolo Radice
Ospedale Circolo e Fondazione Macchi
Career Start Year 1969
Number of shared co-authors 45

Collaborators

Nicholas G Martin
Co-authored papers 48
Grant W Montgomery
Co-authored papers 46
Richard A Scolyer
Co-authored papers 37
Sean M Grimmond
The University of Melbourne
Co-authored papers 23
Ken Dutton-Regester
QIMR Berghofer Medical Research Institute
Co-authored papers 22
Georgina V Long
Co-authored papers 21
Nicola Waddell
QIMR Berghofer Medical Research Institute
Co-authored papers 20
Maria Teresa Landi
National Cancer Institute
Co-authored papers 19
Margaret A Tucker
National Cancer Institute
Co-authored papers 18
John V Pearson
QIMR Berghofer Medical Research Institute
Co-authored papers 15
Richard A Sturm
Frazer Institute, The University of Queensland, Dermatology Research Centre
Co-authored papers 12
Elizabeth M Gillanders
National Cancer Institute, National Institutes of Health
Co-authored papers 12
Christopher I Amos
Baylor College of Medicine
Co-authored papers 11
Ann-Marie Patch
QIMR Berghofer Medical Research Institute
Co-authored papers 11
Anders Molven
Co-authored papers 9
Alison M Dunning
Co-authored papers 9
David J Adams
Wellcome Sanger Institute
Co-authored papers 9
Katia Nones
QIMR Berghofer Medical Research Institute
Co-authored papers 9
Dale R Nyholt
Co-authored papers 8
Xiaohong R Yang
National Cancer Institute
Co-authored papers 7
Jan Lubinski
Pomeranian Medical University
Co-authored papers 7
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 7
Qingyi Wei
South China University of Technology
Co-authored papers 7
G M Lathrop
Co-authored papers 7
Yardena Samuels
Weizmann Institute of Science
Co-authored papers 7
Steven A Rosenberg
University of Colorado School of Medicine
Co-authored papers 6
Grant A McArthur
University of Melbourne
Co-authored papers 6
Douglas F Easton
University of Cambridge
Co-authored papers 6
Georgia Chenevix-Trench
QIMR Berghofer Medical Research Institute
Co-authored papers 6
Jared J Gartner
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 6
Release 1.2